Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000465433 | SCV000541324 | uncertain significance | Alstrom syndrome | 2022-08-09 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 3441 of the ALMS1 protein (p.Arg3441Gly). This variant is present in population databases (rs746702722, gnomAD 0.06%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 403921). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Counsyl | RCV000465433 | SCV000789273 | uncertain significance | Alstrom syndrome | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001539961 | SCV001757789 | likely benign | not provided | 2018-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393076 | SCV002702608 | benign | Cardiovascular phenotype | 2024-07-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000465433 | SCV001465809 | benign | Alstrom syndrome | 2020-11-10 | no assertion criteria provided | clinical testing |